Cargando…
Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
BACKGROUND AND OBJECTIVES: There are limited data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with cancer. We aimed to assess the efficacy and safety of NOACs in AF patients with cancer in this study. METHODS: In 2,568 consecutive non-valvu...
Autores principales: | Kim, Kyu, Lee, Yong-Joon, Kim, Tae-Hoon, Uhm, Jae-Sun, Pak, Hui-Nam, Lee, Moon-Hyoung, Joung, Boyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940645/ https://www.ncbi.nlm.nih.gov/pubmed/29671285 http://dx.doi.org/10.4070/kcj.2017.0328 |
Ejemplares similares
-
Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation
por: Yu, Hee Tae, et al.
Publicado: (2019) -
Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin
por: Shin, Dong Geum, et al.
Publicado: (2016) -
Safety and Efficacy of Switching Anticoagulation to Aspirin Three Months after Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
por: Uhm, Jae-Sun, et al.
Publicado: (2014) -
The safety and efficacy of vitamin K antagonist in atrial fibrillation patients with previous ulcer bleeding: Long-term results from a multicenter study
por: Lee, Seung-Jun, et al.
Publicado: (2016) -
Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation?
por: Yang, Pil-Sung, et al.
Publicado: (2017)